Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.

per Warzocha, K., Bienvenu, J., Ribeiro, P., Moullet, I., Dumontet, C., Neidhardt-Berard, E. M., Coiffier, B., Salles, G.
Publicat 1998